Patent US4622331A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4622331A Expired / Lapsed US ⏱️ 0.0 years remaining

Phenylsulphonamide derivatives, anti-arrhythymic compositions and use

Assignee: Individual
•
Filing: 1985-05-31
•
Granted: 1986-11-11
•
Expires: 2005-05-31
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Pharmaceutical compositions which comprise a compound of the formula (I): ##STR1## or a salt thereof wherein NR 2 represents a piperidyl, pyrrolidyl, morpholino or N-methyl-piperazyl group any of which may substituted by one or two methyl groups; R 1 represents fluorine, chlorine, bromine, iodine, lower alkoxyl, hydroxyl, acetoxyl, nitro, cyano, amino, dimethylamino, lower alkyl, trifluoromethyl, methylthio, ethylthio, methoxycarbonyl, ethoxycarbonyl, acetamido or carboxamido; R 2 represents hydrogen, flurorine, chlorine, bromine, iodine, lower alkoxyl, hydroxyl, lower alkyl; R 3 represents hydrogen, chlorine or lower alkyl; or R 1 and R 2 when on adjacent carbon atoms may together represent a polymethylene group containing from 3 to 5 carbon atoms; and n is 2, 3 or 4; and a pharmaceutically acceptable carrier, compounds of formula (I) except those wherein R 1 is a 2-methoxyl group, and 2,4-dimethyl-1-[2-(4-bromophenylsulphonamido)ethyl]pyrrolidine and 2,4-dimethyl-1-[2-(4-bromophenylsulphonamido)ethyl]pyrrolidine, a process for the preparation of compounds of the formula (I) and 2,4-dimethyl-1-[2-(4-bromophenylsulphonamido)ethyl]pyrrolidine and 2,4-dimethyl-1-[2-(4-iodophenylsulphonamido) ethyl]pyrrolidine as anti-arrhythymic agents.

Inventors

  • 👤 Ljerka Jozic

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 07:17
CPC Classifications
C; C07; C07D; C07D295/00; C07D295/04; C07D295/12; C07D295/125; C07D295/13; A; A61; A61P; A61P9/00; A61P9/06

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 73 words
A compound selected from the group consisting of sulfonamide of the formula: ##STR69## and the pharmaceutically acceptable salts thereof wherein A is a cyclic amino radical selected from the group consisting of piperidino, 2-methylpiperidino and 2,4-dimethylpiperidino, n has a value of 2 or 3, and each of R 2 , R 3 and R 4 is hydrogen or chloro, at least two of R 2 , R 3 and R 4 being chloro.
Claim 2
Dependent Claim 73 words
A compound selected from the group consisting of sulfonamide of the formula: ##STR69## and the pharmaceutically acceptable salts thereof wherein A is a cyclic amino radical selected from the group consisting of piperidino, 2-methylpiperidino and 2,4-dimethylpiperidino, n has a value of 2 or 3, and each of R 2 , R 3 and R 4 is hydrogen or chloro, at least two of R 2 , R 3 and R 4 being chloro.
Claim 3
Dependent Claim 22 words
A compound according to claim 1, wherein n is 3, R 2 and R 3 are chloro, and R 4 is hydrogen.
Claim 4
Dependent Claim 22 words
A compound according to claim 1, wherein n is 3, R 2 is hydrogen, and R 3 and R 4 are chloro.
Claim 5
Dependent Claim 11 words
A compound according to claim 1, wherein said sulfonamide is 2-methyl-1-[3-(2,4,5-trichlorobenzenesulfonamido)propyl]piperidine.
Claim 6
Dependent Claim 26 words
The method of effecting an anti-arrhythmic response in humans and other animals, which comprises administering thereto an effective amount of a compound according to claim 1.
Claim 7
Dependent Claim 25 words
A pharmaceutical composition, comprising an amount of a compound according to claim 1 sufficient to effect an anti-arrhythmic response in combination with a pharmaceutical carrier.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-11-10 1990-05-12 1990-11-11 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-11-10 1994-05-12 1994-11-11 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-11-10 1998-05-12 1998-11-11 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag